Genmab — November 2020
-
Hvorfor i dag og ikke i morgen? Jeg er lang i aktien, så købstidspunktet er ikke så relevant, men jeg vil hellere købe dagen før end dagen efter nyheden - der, som jeg skrev tidligere, kommer uanmeldt. Men i forbindelse med ASH er et godt bud.Nu har aktien bumlet rundt omkring 2200-2400 siden august. Min tanke er, at turen mod 2500 starter snart og vi så i en ikke fjern fortid, at aktien steg 300 point på 2 dage, når først folket vil med på toget.
-
Spørgsmål til Q&A er meget velkommen.
-
@StockBull we will most certainly keep saying that, it is part of the fun
I can already hear the complaints and the misery and how we 'really need some good ASCO news', when we will fall back from 3100 to 3000 
-
Der var nogen der nåede at blive kørt over....
-
Ja det hjalp ikke meget...
-
probably why they linked to their pipeline just an hour ago lol https://twitter.com/Genmab/status/1331236652501622785
-
Spændende om det går som det plejer...falder på "gode" nyheder.
-
It is very annoying to end a day like this with a statement of termination. Same Time seeing the market already anticipated such development from opening hour at 9 am. Maybe Jan can elaborate how such a call has been taken and approved and who knows such
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind